hero image
Dr. Vera Bril - University Health Network. Toronto, ON, CA

Dr. Vera Bril Dr. Vera Bril

Medical Director - Krembil Neuroscience Centre | University Health Network

Toronto, ON, CANADA

Neurologist and researcher focused on the diagnosis and management of patients with complex neuromuscular disorders



Dr. Vera Bril Publication



loading image loading image loading image


AAN Issues New Guidelines on Best Treatments for Diabetic Nerve Pain




Dr. Vera Bril is a Professor of Medicine (Neurology) at the University of Toronto, Director of Neurology at University Health Network and Mount Sinai Hospital and the Krembil Family Chair in Neurology. She has particular expertise in the diagnosis and management of patients with complex neuromuscular disorders. Her research interests have centred on the diagnosis and evidence-based treatment of myasthenia gravis, inflammatory polyneuropathies, and diabetic sensorimotor polyneuropathy. Her work has helped set the standards for electrophysiological investigations in the definition and evaluation of the progression of chronic polyneuropathies. Her research has helped establish the role of intravenous immunoglobulin in the treatment of myasthenia gravis and the Guillain-Barr Syndrome, and the long-term treatment of chronic inflammatory demyelinating polyneuropathy. She has acted in an advisory capacity to Health Canada and the FDA.

Dr. Bril also serves as the Deputy Physician-in-Chief for Economic Affairs for the Department of Medicine at University Health Network and Mount Sinai Hospital and Chair of the Economics committee. She is part of the Department of Medicine Executive Committee and helps administer this group of 300 physicians.

Industry Expertise (6)


Health Care - Services

Health Care - Providers

Health Care - Facilities

Health and Wellness


Areas of Expertise (10)


Neuromuscular Disorders

Myasthenia Gravis

Inflammatory Polyneuropathies

Diabetic Sensorimotor Polyneuropathy

Guillan-Barr Syndrome

Chronic Polyneuropathies

Neural and Sensory Sciences

Intravenous Immunoglobulin

Chronic Inflammatory Demyelinating Polyneuropathy (Cidp)

Affiliations (6)

  • University of Toronto : Professor, Department of Medicine (Neurology)
  • University Health Network and Mount Sinai Hospital: Head, Division of Neurology
  • Neuromuscular Program: Director
  • Krembil Family Chair in Neurology
  • University Health Network and Mount Sinai Hospital: Deputy Physician-in-Chief, Economic Affairs, Department of Medicine
  • Economics committee: Chair

Media Appearances (3)

Dr Vera Bril places “first-in-class” in Canadian Diabetes Association research granting competition

The Brain Campaign  online


The Competition for peer reviewed research funding is fierce. Countless researchers around the country, and in some cases, the world, work for months preparing grant funding requests; defend their applications before committees made up of national and international experts and people living the respective disease; and answer detailed questions about their submission to receive scarce funding for their research projects...

view more

Dr. M. Barbara Berner establishes Fellowship

UHN General & Western Hospital Foundation  online


Treated by Dr. Vera Bril, leader of the Neuromuscular Clinic at UHN, ever since, Dr. Berner recently expressed her gratitude profoundly. By funding both a fellowship in neuromuscular research – as well as confirming an annual gift to support the current fellowship, and leaving a more significant gift in her Will to support the fellowship in perpetuity – Dr. Berner's support promises to make a sizable difference in MG treatments, both now and into the future...

view more

Neurology Podcast

American Academy of Neurology  online


This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns with Dr. Paola Sandroni about her paper on orthostatic intolerance. Dr. Jennifer Fugate is reading our e-Pearl of the week about bright tongue sign. In the next part of the podcast Dr. Ted Burns interviews Dr. Vera Bril about symptomatic treatment of painful diabetic neuropathy...

view more

Event Appearances (1)

Diagnosis and Management of CIDP

CBS/CIDP Douncation of Canada, National Conference  Toronto, ON.


Articles (6)

Evidence-based guideline: Treatment of painful diabetic neuropathy American Academy of Neurology


The basic question asked was: “What is the efficacy of a given treatment (pharmacological: anticonvulsants, antidepressants, opioids, others; and non-pharmacological: electrical stimulation, magnetic field treatment, low-intensity laser treatment, Reiki massage, others) to reduce pain and improve physical function and quality of life (QOL) in patients with PDN?”

view more

Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial The Lancet


Short-term studies suggest that intravenous immunoglobulin might reduce disability caused by chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) but long-term effects have not been shown. We aimed to establish whether 10% caprylate- ...

view more

Diabetic Neuropathies : A Statement by the American Diabetes Association American Diabetes Association


The diabetic neuropathies are hetero-geneous, affecting different parts of the nervous system that present with diverse clinical manifestations. They may be focal or diffuse. Most common among the neuropathies are chronic sensorimotor distal symmetric ...

view more

Simple screening tests for peripheral neuropathy in the diabetes clinic Diabetes Care


The utility of rapid and reliable sensory tests appropriate for the diagnosis of neuropathy in the diabetes clinic, rather than as prognostic tools for the prediction of foot complications, has been unclear because of limitations inherent in previous studies. ...

view more

Regeneration and Repair of Myelinated Fibers in Sural-Nerve Biopsy Specimens from Patients with Diabetic Neuropathy Treated with Sorbinil The New England Journal of Medicine


There is reason to believe that diabetic neuropathy may be related to the accumulation of sorbitol in nerve tissue through an aldose reductase pathway from glucose. Short-term treatment with aldose reductase inhibitors improves nerve conduction in ...

view more

Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy The Journal of Clinical Investigation


Altered sorbitol and myo-inositol metabolism,(Na, K)-ATPase function, electrochemical sodium gradients, axonal swelling, and distortion and disruption of the node of Ranvier (" axo-glial dysjunction") directly implicate hyperglycemia in the pathogenesis ...

view more